These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9815754)

  • 21. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
    Jayasinghe UW; Bilous AM; Boyages J
    Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
    Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.
    Caffo O; Doglioni C; Veronese S; Bonzanini M; Marchetti A; Buttitta F; Fina P; Leek R; Morelli L; Palma PD; Harris AL; Barbareschi M
    Clin Cancer Res; 1996 Sep; 2(9):1591-9. PubMed ID: 9816338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer: poor short-term prognosis in cases with moderate lymphocyte infiltration at the tumour edge: a preliminary report.
    Hartveit F
    Oncol Rep; 1998; 5(2):423-6. PubMed ID: 9468572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of tumor size and lymph node status on breast carcinoma lethality.
    Michaelson JS; Silverstein M; Sgroi D; Cheongsiatmoy JA; Taghian A; Powell S; Hughes K; Comegno A; Tanabe KK; Smith B
    Cancer; 2003 Nov; 98(10):2133-43. PubMed ID: 14601082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma.
    Planchard D; Soria JC; Michiels S; Grunenwald D; Validire P; Caliandro R; Girard P; Le Chevalier T
    Cancer; 2004 Jan; 100(1):28-35. PubMed ID: 14692021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
    Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twenty-five years of follow-up in patients with operable breast carcinoma: correlation between clinicopathologic factors and the risk of death in each 5-year period.
    Arriagada R; Le MG; Dunant A; Tubiana M; Contesso G
    Cancer; 2006 Feb; 106(4):743-50. PubMed ID: 16411216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan.
    Wernicke M; Piñeiro LC; Caramutti D; Dorn VG; Raffo MM; Guixa HG; Telenta M; Morandi AA
    Mod Pathol; 2003 Feb; 16(2):99-107. PubMed ID: 12591961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast carcinoma survival in Europe and the United States.
    Sant M; Allemani C; Berrino F; Coleman MP; Aareleid T; Chaplain G; Coebergh JW; Colonna M; Crosignani P; Danzon A; Federico M; Gafà L; Grosclaude P; Hédelin G; Macè-Lesech J; Garcia CM; Møller H; Paci E; Raverdy N; Tretarre B; Williams EM;
    Cancer; 2004 Feb; 100(4):715-22. PubMed ID: 14770426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
    Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
    Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
    Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas.
    Puglisi F; Barbone F; Tell G; Aprile G; Pertoldi B; Raiti C; Kelley MR; Damante G; Sobrero A; Beltrami CA; Di Loreto C
    Oncol Rep; 2002; 9(1):11-7. PubMed ID: 11748448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.